ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $27,339,000 | -29.8% | 676,379 | +0.0% | 3.72% | -24.0% |
| Q2 2015 | $38,924,000 | -9.6% | 676,350 | +0.0% | 4.90% | -9.0% |
| Q1 2015 | $43,061,000 | +3.1% | 676,323 | +0.0% | 5.38% | +3.6% |
| Q4 2014 | $41,756,000 | +59.0% | 676,313 | +0.0% | 5.20% | +50.4% |
| Q3 2014 | $26,261,000 | +12.7% | 676,298 | 0.0% | 3.46% | +14.9% |
| Q2 2014 | $23,298,000 | -20.3% | 676,298 | 0.0% | 3.01% | -21.8% |
| Q1 2014 | $29,223,000 | +8.5% | 676,298 | +0.1% | 3.85% | +1.7% |
| Q4 2013 | $26,924,000 | +6.1% | 675,798 | 0.0% | 3.78% | -4.8% |
| Q3 2013 | $25,369,000 | +21.7% | 675,798 | -12.9% | 3.98% | +14.6% |
| Q2 2013 | $20,846,000 | – | 775,798 | – | 3.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,729,426 | $364,793,000 | 10.87% |
| DOWLING & YAHNKE LLC | 676,323 | $43,061,000 | 5.38% |
| WILLIAM HARRIS INVESTORS INC | 229,887 | $14,638,000 | 3.84% |
| Opus Point Partners Management, LLC | 60,912 | $3,878,000 | 3.25% |
| Nepsis Inc. | 64,580 | $4,112,000 | 2.48% |
| Private Capital Advisors, Inc. | 106,320 | $6,769,000 | 2.46% |
| PINNACLE ASSOCIATES LTD | 1,889,017 | $120,274,000 | 2.24% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 20,947 | $1,333,000 | 1.90% |
| Apex Capital Management | 928,654 | $59,127,000 | 1.39% |
| Bellevue Asset Management AG | 147,000 | $9,359,000 | 1.31% |